Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.96ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.96ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.1.96NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.96NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.96NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
L.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
L.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
L.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
L.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.310ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.310ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
AE.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.6ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
N.6ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
N.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.36ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.36ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.407ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.1.407ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.1.1.407NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.407NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.407NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.20ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.20ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.423ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.1.423ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.1.1.423NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.423NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.423NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.281ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.281ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.1.281NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.281NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.281NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.6ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
AE.6ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
AE.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used